《美股业绩》西南航空上季蚀11.6亿美元
西南航空(Southwest Airlines)(LUV.US)第三季度亏损11.6亿美元,是公司历年来最大的亏损,收入下降68.2%至17.9亿美元。不过由於预订量有复苏的迹象,预计未来数个月的现金消耗量将会减少。
西南航空预计第四季平均核心现金消耗为每日1,100万美元,较第三季度的1,600万美元为少。
公司表示,将从12月1日起恢复出售所有可售的座位,不再空置飞机中间座位,但警告在疫苗广泛接种之前,旅游需求仍然疲弱。
由於美国民主党众议院议长佩洛西表示,纾困方案愈来愈接近达成协议,隔夜航空股造好,西南航空股价急升逾5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.